Immunogen | Ativo Circulante



Current Assets Alterar Data
AbbVie USD 25.58B 2.2B 2024-12
Agios Pharmaceuticals USD 968.62M 3.02M 2025-03
Amgen USD 26.93B 2.1B 2025-03
Astellas Pharma JPY 1.2T 2.56B 2025-03
AstraZeneca USD 26.14B 312M 2025-03
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Eli Lilly USD 41.26B 8.52B 2025-03
Exelixis USD 1.4B 71.08M 2025-04
Halozyme Therapeutics USD 1.26B 176.69M 2025-03
MacroGenics USD 217.49M 4.71M 2024-12
Novartis USD 29.7B 1.56B 2024-12
Pfizer USD 45.86B 4.5B 2025-03
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 42.59B 12.51B 2024-12



Immunogen Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.